ESCRS 2021: An Invite from Glaukos
Andrew Geddes, Vice President, Commercial – Europe, Middle East & India at Glaukos, talks about the company's plans for this year's ESCRS Meeting
sponsored by Glaukos
The ESCRS Meeting is a great opportunity for all attendees – both in person and virtual – to learn how iStent inject® W helps improve patients’ quality of life by reducing or eliminating the need for medications – both decreasing IOP and improving ocular surface outcomes.
Additionally, we will show how iLinkTM V can slow or halt keratoconus when patients are treated with the KXL® System using VibeX® Rapid riboflavin. We will have our specialist team available to meet you at our booth in a safety-conscious environment.
Our dual lunchtime interactive symposia enable surgeons to attend both days’ seminars and benefit from the experience of international speakers specializing in mild to moderate glaucoma and CXL treatment.
Surgeons visiting the Glaukos booth will learn about our latest technologies for their mild to moderate glaucoma surgical options, and how to best improve their keratoconic patients’ quality of life through our KXL® treatment options combined with our Vibex® product range.
Booth Number A23
Symposia: Preserve your Patients’ Quality of Life with iStent inject® W Trabecular Micro- Bypass, October 9, 11:45 to 12:45pm
Transforming the Standard of Care for Keratoconus with iLinkTM V, October 10, 11.45 am-12.45 pm.
